(11 days)
Not Found
No
The summary describes standard image processing, visualization, measurement, and registration tools, without mentioning AI, ML, or related concepts like deep learning, neural networks, or training/test sets for algorithmic development.
No.
The device is described as a "visualization package" and "digital medical image processing tool" intended to "support" medical professionals in "reading, analysis and diagnosis" of medical datasets. It does not directly provide therapy or therapeutic intervention.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is "intended to support radiographer, medical imaging technician, radiologist and referring physician in the reading, analysis and diagnosis of DICOM compliant volumetric medical datasets." The repeated mention of "diagnosis" clearly indicates its diagnostic purpose.
Yes
The device is described as a "software package" and "software accessory" for a PACS system, with no mention of accompanying hardware components being part of the device itself. Its function is solely image processing and visualization.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device's function: The description clearly states that Impax Volume Viewing is a software package for visualizing and processing medical images (DICOM compliant volumetric datasets from modalities like CT and MR). It works with images already acquired from the patient, not with samples taken from the patient.
- Intended Use: The intended use is for reading, analysis, and diagnosis of these images, facilitating visualization, measurement, and comparison of anatomical structures and lesions. This is image-based analysis, not laboratory testing of biological samples.
The device is a medical image processing and visualization tool, which falls under a different category of medical devices than IVDs.
N/A
Intended Use / Indications for Use
Impax Volume Viewing software is a visualization package for PACS workstations. It is intended to support radiographer, medical imaging technician, radiologist and referring physician in the reading, analysis and diagnosis of DICOM compliant volumetric medical datasets. The software is a general purpose digital medical image processing tool, with optional functionality to facilitate visualization and measurement of vessel features.
Other optional functionality is intended for the registration of anatomical (CT) on functional volumerric image data (MR) to facilitate the comparison of various lesions. Volume and distance measurements are intended for evaluation and quantification of tumor measurements, and other analysis and evaluation of both hard and soft tissues. The software also supports interactive segmentation of a region of interest (ROI).
Product codes
LLZ
Device Description
The new device is similar to the predicate devices. All are PACS system accessories that allow the user to view and manipulate three dimensional image data sets.
Principles of operation and technological characteristics of the new and predicate devices are the same. The intended uses of the new and predicate devices are also the same.
Impax Volume Viewing is a software accessory to Agfa's Impax Picture Archiving and Communications system.
It is a tool for conveniently viewing and manipulating cross-sectional image series' for display in any orientation and slice thickness. A second series can be registered or fused to the first automatically, manually or with user defined landmarks. Segmentation of blood vessels and airfilled structures facilitate the visualization of vessel features. Color maps, subtraction views, multiple screen layouts and tools for measurement, calculations and annotations are provided.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT and MR
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
radiographer, medical imaging technician, radiologist and referring physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Verification and validation testing confirm the device meets performance, measurement and usability requirements. No clinical trials were performed in the development of the device.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
K 111638
JUN 2 4 2011
510(K) SUMMARY: IMPAX VOLUME VIEWING
Common/Classification Name: Picture Archiving and Communications System 21 CFR 892.2050 Proprietary Name: Impax Volume Viewing Agfa HealthCare N.V. Septestraat 27 B-2640 Mortsel Belgium Contact: Koen Cobbaert, Prepared: May 6, 2011 Telephone: 32 3 444 7539
LEGALLY MARKETED PREDICATE DEVICES A.
This is a 510(k) for Agfa's Impax Volume Viewing software, which is an accessory to its Impax picture archiving and communications systems. It is substantially equivalent to Agfa's Registration and Fusion software (K080013) in the majority of its functionality and to the Voxar 3D Enterprise with ColonMetrix and PET/CT Perfusion (K070831) with respect to its vessel viewing functionality.
B. DEVICE DESCRIPTION
The new device is similar to the predicate devices. All are PACS system accessories that allow the user to view and manipulate three dimensional image data sets.
Principles of operation and technological characteristics of the new and predicate devices are the same. The intended uses of the new and predicate devices are also the same.
c. INTENDED USE
Impax Volume Viewing software is a visualization package for PACS workstations. It is intended to support radiographer, medical imaging technician, radiologist and referring physician in the reading, analysis and diagnosis of DICOM compliant volumetric medical datasets. The software is a general purpose digital medical image processing tool, with optional functionality to facilitate visualization and measurement of vessel features.
Other optional functionality is intended for the registration of anatomical (CT) on functional volumerric image data (MR) to facilitate the comparison of various lesions. Volume and distance measurements are intended for evaluation and quantification of tumor measurements, and other analysis and evaluation of both hard and soft tissues. The software also supports interactive segmentation of a region of interest (ROI).
D. SUBSTANTIAL EQUIVALENCE SUMMARY
Agfa's Impax Volume Viewing has an Indications For Use Statement largely similar to the statements for the two predicate. Intended uses are the same. As software accessories to PACS systems, the predicate and new devices have the same technological characteristics. Software is used to identify characteristic patterns within 3D image data which the user can then view and manipulate. Descriptive characteristics and performance data are adequate to ensure equivalence.
Differences in the new device and the predicates do not alter their intended therapeutic/diagnostic effects.
1
Agfa HealthCare NV
Premarket Notification: Impax Volume Viewing
l
| PRODUCT COMPARISON TABLE | |||
|---|---|---|---|
| Impax | |||
| Volume Viewing | |||
| (NEW DEVICE) | Impax | ||
| Registration and Fusion | |||
| (PREDICATE K080013) | Voxar 3D Enterprise | ||
| with ColonMetrix and | |||
| PET/CT Perfusion | |||
| (PREDICATE K070831) | |||
| 3D Volume rendering | √ | √ | √ |
| MPR CPR | √ | MPR | √ |
| MIP MiniP AveIP | √ | MIP | √ |
| Fusion and subtraction views | √ | √ | - |
| Can load and register two data sets for comparison | √ | √ | - |
| Multi-modality (CT and MR) image registration | √ | √ | - |
| Vessel analysis | √ | - | √ |
| Manual slice by slice volume-of-interest | √ | √ | - |
| DICOM and AVI movie generation | √ | √ | √ |
| Reformat to a new dataset | √ | √ | √ |
| Color maps | √ | √ | √ |
| Annotations and measurements | √ | √ | √ |
| Automatic table top removal | √ | √ | √ |
| User Interface | Impax | Impax | Voxar |
·
5 - 4
·
2
TECHNOLOGICAL CHARACTERISTICS C.
Impax Volume Viewing is a software accessory to Agfa's Impax Picture Archiving and Communications system.
It is a tool for conveniently viewing and manipulating cross-sectional image series' for display in any orientation and slice thickness. A second series can be registered or fused to the first automatically, manually or with user defined landmarks. Segmentation of blood vessels and airfilled structures facilitate the visualization of vessel features. Color maps, subtraction views, multiple screen layouts and tools for measurement, calculations and annotations are provided.
F. TESTING
Verification and validation testing confirm the device meets performance, measurement and usability requirements. No clinical trials were performed in the development of the device.
The new device and Agfa's management systems conform to the following standards:
- EN12435:2006 Health Informatics Expression of Results of Measurements in Health ● Sciences
- . ISO 14971:2007 - Application of Risk Management to Medical Devices
- ISO 13485:2003 Medical Devices Quality Management Systems Requirements For . Regulatory Purposes
CONCLUSIONS G.
This 510(k) has demonstrated Substantial Equivalence as defined and understood in the Federal Food Drug and Cosmetic Act and various guidance documents issued by the Center for Devices and Radiological Health.
3
Image /page/3/Picture/0 description: The image shows the logo of the U.S. Department of Health and Human Services. The logo consists of a stylized human figure with three arms, enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around it. The text "DEPARTMENT" is written in bold, sans-serif font to the right of the logo.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
AGFA Healthcare N.V. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO NY 55313
AUG 2 3 2013
Re: K111638
Trade/Device Name: Impax Volume Viewing Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: June 10, 2011 Received: June 13, 2011
Dear Mr. Job:
This letter corrects our substantially equivalent letter of June 24, 2011.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The I va may a controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must or mr) 2 vith all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
4
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours,
Janine M. Morris
Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known):
Device Name: Impax Volume Viewing
Indications for Use:
Impax Volume Viewing is a visualization package for PACS workstations. It is intended to support radiographer, medical imaging technician, radiologist and referring physician in the reading, analysis and diagnosis of DICOM compliant volumetric medical datasets. The software is intended as a general purpose digital medical image processing tool, with optionality to facilitate visualization and measurement of vessel features.
Other optional functionality is intended for the registration of anatomical (CT) on functional volumetric image data (MR) to facilitate the comparison of various lesions. Volume and distance measurements are intended for evaluation and quantification of tumor measurements, and other analysis and evaluation of both hard and soft tissues. The software also supports interactive segmentation of a region of interest (ROI).
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Mary S Patil
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K111638
Page 1 of
FDA CDRH DMC